GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (OTCPK:HNGZY) » Definitions » Total Stockholders Equity

HNGZY (Hangzhou Tigermed Consulting Co) Total Stockholders Equity : $2,831.9 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Total Stockholders Equity?

Hangzhou Tigermed Consulting Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $2,831.9 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hangzhou Tigermed Consulting Co's Book Value per Share for the quarter that ended in Mar. 2025 was $3.27. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hangzhou Tigermed Consulting Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.15.


Hangzhou Tigermed Consulting Co Total Stockholders Equity Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Total Stockholders Equity Chart

Hangzhou Tigermed Consulting Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,464.88 2,845.47 2,808.93 2,944.84 2,839.10

Hangzhou Tigermed Consulting Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,934.37 2,862.31 2,976.96 2,839.10 2,831.90

Hangzhou Tigermed Consulting Co  (OTCPK:HNGZY) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hangzhou Tigermed Consulting Co's Book Value per Share for the quarter that ended in Mar. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hangzhou Tigermed Consulting Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Tigermed Consulting Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Tigermed Consulting Co Business Description

Traded in Other Exchanges
Address
Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co Headlines

From GuruFocus

Tigermed Reports Strong 2021 Full-Year Results

By PRNewswire PRNewswire 03-28-2022

Tigermed Reports 2024 Interim Results

By PRNewswire 08-28-2024

Tigermed Reports Full Year 2023 Results

By PRNewswire 03-28-2024

Tigermed Reports 2023 Interim Results

By PRNewswire 08-25-2023

Tigermed Completes Acquisition of Marti Farm

By PRNewswire PRNewswire 01-19-2023

Tigermed Reports Full Year 2024 Results

By PRNewswire 03-27-2025